Jul 2026· Chemical Communications· Vol 62, pp. 14873-14889· 0 citations· 140 references
Medicine
TL;DR
A central theme is emphasised: that generative AI delivers speed and breadth, while physics-based simulation supplies thermodynamic rigour, and that their integration, rather than either alone, defines the most promising path forward.
Abstract
Allostery offers a powerful route to regulate protein function and expands drug discovery beyond the orthosteric paradigm. By acting at sites distinct from the active site, allosteric modulators can achieve greater selectivity, reduce off-target effects, and overcome resistance. The discovery of the cryptic switch-II pocket of KRAS, which turned a long-"undruggable" oncoprotein into a clinically validated target, exemplifies this promise. Yet allosteric drug discovery is demanding: it requires not only identifying a suitable, often transient pocket, but also demonstrating that this pocket is functionally coupled to the active site, and then translating that mechanistic insight into design. This perspective surveys the computational strategies addressing each of these challenges in turn: sequence, structure, and machine-learning-based methods for locating allosteric and cryptic sites; network and dynamical analyses for mapping communication pathways; and enhanced-sampling and generative deep-learning approaches for rational modulator design. Throughout, we emphasise a central theme: that generative AI delivers speed and breadth, while physics-based simulation supplies thermodynamic rigour, and that their integration, rather than either alone, defines the most promising path forward. Together with experimental validation, these advances are rapidly expanding our ability to exploit allosteric regulation in therapeutics.
A structural database that systematically maps the complete activation trajectories of pharmaceutically relevant targets, encompassing TS, IS, and all connecting conformational ensembles is presented, offering multiple strategic advantages for drug discovery.
The structural and medicinal chemistry principles underlying (i) allosteric inhibition and (ii) proximity-induced degradation are summarized, with an emphasis on design logic, structure-activity relationships, and key liabilities in the beyond rule of five space.
Mei Zhou, Linshan Li, Xiao-Juan Tang et al.· Future Medicinal Chemistry· 0 citations
A machine learning-guided structural atlas of 11,945 kinase-inhibitor complexes is constructed and it is demonstrated that evolutionary proximity is a statistically significant predictor of shared allosteric pocket accessibility, making drug discovery more efficient.
Rudrakshi Chauhan, Rajiah Aldrin Denny, N. Murugan· bioRxiv· 0 citations
The central theme, conformational analysis, links on-target potency via pre-organization of the bioactive conformation with physics-based physicochemical property prediction with physics-based physicochemical property prediction, highlighting neutral polarity as a key determinant of permeability and exposure.
Targeting the orthosteric site of G protein-coupled receptors (GPCRs) has long dominated drug discovery, but intracellular allosteric modulators (AMs) provide new avenues to enhance selectivity and fine-tune signaling. Recent structural advances have illuminated intracellular allosteric pockets that act as conformation...
Yang Zhou, Alan Long, Joshua D. Gross et al.· TIPS - Trends in Pharmacolog...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.